LEO Pharma Open Innovation

Structural confidentiality


Protecting your compounds

LEO Pharma’s Open Innovation invites you to submit compounds for test in disease-relevant in vitro assays. We are looking for new possible collaborations to develop new drugs for future treatments, all while respecting your integrity, trust and need for confidentiality.

To ensure compound confidentiality we do not ask for structures of confidential compounds – that information will remain with you until we mutually agree otherwise.